IRMD | iRadimed CorporationNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$81.11
+$1.69 (+2.13%)

iRadimed Corporation (IRMD) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $81.11 vs 50 $85.37 / 200 $92.32
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Aug 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $76.68 vs 50 $92.82 / 200 $60.61
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
below both $81.01 vs 50 $86.13 / 200 $89.42
Projection
No cross projected
Test
No active test
Last cross
Death cross 20 Aug 2026 ยท projected 16 bars out

Cross history

27
crosses on record since 2017
13 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Aug 2026Death4-hour16 bars outNot tested
13 Aug 2026Death flatdaily30 bars outNot tested
13 Jul 2026Golden moderatedaily20 bars out3 bar cross test
9 Jul 2026Golden4-hour20 bars out1 bar cross test
23 Jun 2026Death flatdaily7 bars outNot tested

About IRMD

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.